Disposition of 82734 shares by Lee Jeong James of Chromadex Corp at 1.52 subject to Rule 16b-3

CDXC Stock  USD 7.44  0.19  2.49%   
About 61% of Chromadex Corp's investor base is looking to short. The analysis of overall sentiment of trading Chromadex Corp stock suggests that many investors are alarmed at this time. The current market sentiment, together with Chromadex Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Chromadex Corp stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Chromadex Corp Officer Interim Cfo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 82734 employee stock options (right to buy) at 1.52 of Chromadex Corp by Lee Jeong James on 18th of September 2024. This event was filed by Chromadex Corp with SEC on 2025-02-22. Initial filing of beneficial ownership - SEC Form 3

Cash Flow Correlation

Chromadex Corp's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Chromadex Corp's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Chromadex Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Chromadex Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Chromadex Corp Fundamental Analysis

We analyze Chromadex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chromadex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chromadex Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

Chromadex Corp is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Chromadex Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chromadex Corp stock to make a market-neutral strategy. Peer analysis of Chromadex Corp could also be used in its relative valuation, which is a method of valuing Chromadex Corp by comparing valuation metrics with similar companies.

Peers

Chromadex Corp Related Equities

XCURExicure   69.24   
0%
100.0%
ANTXAN2 Therapeutics   8.94   
0%
12.0%
HCWBHCW Biologics   8.45   
0%
12.0%
JANXJanux Therapeutics   8.19   
0%
11.0%
MNOVMediciNova   6.50   
0%
9.0%
MLYSMineralys Therapeutics,   5.22   
0%
7.0%
AVTEAerovate Therapeutics   1.92   
0%
2.0%
ACRVAcrivon Therapeutics,   1.71   
0%
2.0%
RZLTRezolute   1.03   
0%
1.0%
IKNAIkena Oncology   1.16   
1.0%
0%
KZRKezar Life   1.57   
2.0%
0%
NKTXNkarta   2.40   
3.0%
0%
IPSCCentury Therapeutics   2.42   
3.0%
0%
ELYMEliem Therapeutics   2.60   
3.0%
0%
ANEBAnebulo Pharmaceuticals   2.67   
3.0%
0%
ADAGAdagene   3.10   
4.0%
0%

Complementary Tools for Chromadex Stock analysis

When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stocks Directory
Find actively traded stocks across global markets